A technology-based enterprise dedicated to non-invasive early screening and diagnosis of colorectal cancer

On July 20, 2020, General Manager Tan Shengwei led the management team, partners, and relevant responsible persons of Lixin Nuokang (Shandong) subsidiary to sign the project landing agreement and factory decoration contract in Yinan County, Shandong Province.

As a technology and biotechnology enterprise, Linaxin registered a wholly-owned subsidiary in Shandong in 2020 as the production base for our products and reached a cooperation agreement with the government of Yinan County, Shandong to create a model market and lay the foundation for the listing of our products.

        LNX Bio was founded in 2019 and is a technology-based company specializing in non-invasive early screening diagnosis of colorectal cancer. It is committed to developing portable cancer precision detectors and test kits. LNX Bio has over ten years of experience in nano chip research and development, as well as nano chip cancer precision detection. The company has a core team of experts in the gene sequencing industry, including senior experts in micro nano processing manufacturing, biochemistry, integrated circuits, organic synthesis, mechanical engineering, materials engineering, cloud storage and other professional fields from both China and abroad. Advocate for a new health concept of prevention in the new era and improve the health level of all humanity.

Corporate mission: To make genetic sequencing a routine testing and diagnostic tool, and to improve the health level of all humanity.